PHARMACOLOGICAL CHARACTERIZATION OF TYPE-II GLUCOCORTICOID BINDING-SITES IN ATT20 PITUITARY CELL-CULTURE

被引:7
|
作者
GANNON, MN
SPENCER, RL
LUNDBLAD, JR
MCEWEN, BS
ROBERTS, JL
机构
[1] ROCKEFELLER UNIV,DEPT NEUROENDOCRINOL,NEW YORK,NY 10021
[2] CUNY MT SINAI SCH MED,FISHBERG RES CTR NEUROBIOL,NEW YORK,NY 10029
关键词
D O I
10.1016/0022-4731(90)90116-A
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent evidence indicates that at least two functional glucocorticoid receptors (Type I and Type II) are present in many tissues. It has also become increasingly recognized that, as in other systems, stimulus-response relationships for steroid hormones are often nonlinear. Thus, precise pharmacological parameters are required to establish a functional relationship(s) between binding site and response characteristics. We therefore pharmacologically characterized a glucocorticoid binding site present in AtT20 mouse pituitary cells, a cell line extensively used in studying Type II glucocorticoid receptor function. By several different criteria, glucocorticoids were shown to bind to a single class of binding sites, which, in comparison to available literature, correspond to classical Type II glucocorticoid receptors. No evidence for Type I adrenal steroid binding sites was observed, under the experimental conditions used. Unambiguous Kb values for both glucocorticoid agonists and antagonists were therefore calculated. These parameters should prove of use in elucidating the relationships between glucocorticoid receptor activation and different responses in both AtT20 cells and other glucocorticoid responsive tissues. © 1990.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 50 条
  • [1] THE PROOPIOMELANOCORTIN (POMC) GENE-EXPRESSION OF ATT20 MOUSE PITUITARY-CELLS IS DEPENDENT ON CELL-CULTURE CONDITIONS
    FICKEL, J
    SAVOLY, S
    VOGEL, U
    FURKERT, J
    MELZIG, M
    CELLULAR AND MOLECULAR BIOLOGY, 1994, 40 (02) : 201 - 209
  • [2] AN ENDOGENOUS LIGAND FOR TYPE-II ESTROGEN BINDING-SITES
    MARKAVERICH, BM
    ROBERTS, RR
    ALEJANDRO, MA
    CLARK, JH
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1626 - 1626
  • [3] PRELIMINARY CHARACTERIZATION AND PARTIAL-PURIFICATION OF RAT UTERINE NUCLEAR TYPE-II BINDING-SITES
    MARKAVERICH, BM
    GREGORY, RR
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (03) : 1283 - 1290
  • [4] PHARMACOLOGICAL CHARACTERIZATION OF ANGIOTENSIN-II BINDING-SITES IN THE CANINE PANCREAS
    CHAPPELL, MC
    DIZ, DI
    JACOBSEN, DW
    PEPTIDES, 1992, 13 (02) : 313 - 318
  • [5] TYPE-II ESTROGEN BINDING-SITES IN ACUTE LYMPHOID AND MYELOID LEUKEMIAS
    BLACKBURN, EK
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (04) : 563 - 563
  • [6] THE EOSINOPHILIC ORIGIN OF THE UTERINE NUCLEAR TYPE-II ESTROGEN BINDING-SITES
    LYTTLE, CR
    MEDLOCK, KL
    SHEEHAN, DM
    JOURNAL OF CELL BIOLOGY, 1983, 97 (05): : A155 - A155
  • [7] TYPE-II ESTROGEN BINDING-SITES IN HUMAN COLORECTAL-CARCINOMA
    PIANTELLI, M
    RICCI, R
    LAROCCA, LM
    RINELLI, A
    CAPELLI, A
    RIZZO, S
    SCAMBIA, G
    RANELLETTI, FO
    JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (12) : 1004 - 1006
  • [8] EOSINOPHILS AS THE SOURCE OF UTERINE NUCLEAR TYPE-II ESTROGEN BINDING-SITES
    LYTTLE, CR
    MEDLOCK, KL
    SHEEHAN, DM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1984, 259 (05) : 2697 - 2700
  • [9] BIOFLAVONOID INTERACTION WITH RAT UTERINE TYPE-II BINDING-SITES AND CELL-GROWTH INHIBITION
    MARKAVERICH, BM
    ROBERTS, RR
    ALEJANDRO, MA
    JOHNSON, GA
    MIDDLEDITCH, BS
    CLARK, JH
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1988, 30 (1-6): : 71 - 78
  • [10] TYPE-II ESTROGEN BINDING-SITES AND ANTIPROLIFERATIVE ACTIVITY OF QUERCETIN IN HUMAN MENINGIOMAS
    PIANTELLI, M
    RINELLI, A
    MACRI, E
    MAGGIANO, N
    LAROCCA, LM
    SCERRATI, M
    ROSELLI, R
    IACOANGELI, M
    SCAMBIA, G
    CAPELLI, A
    RANELLETTI, FO
    CANCER, 1993, 71 (01) : 193 - 198